EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -237.20
March 31, 2026 -3.256
December 31, 2025 405.14
September 30, 2025 -2.818
June 30, 2025 -385.90
March 31, 2025 -3.228
December 31, 2024 -17.82
September 30, 2024 -20.52
June 30, 2024 -14.94
March 31, 2024 -16.11
December 31, 2023 -20.55
September 30, 2023 -66.29
June 30, 2023 -96.52
March 31, 2023 -100.64
December 31, 2022 -115.87
Date Value
September 30, 2022 -119.54
June 30, 2022 -108.56
March 31, 2022 -115.46
December 31, 2021 -127.12
September 30, 2021 -172.03
June 30, 2021 -176.26
March 31, 2021 -149.79
December 31, 2020 -160.80
September 30, 2020 -137.31
June 30, 2020 -150.26
March 31, 2020 -148.43
December 31, 2019 -142.43
September 30, 2019 -124.63
June 30, 2019 -109.79

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 0.1812
Cue Biopharma, Inc. -24.14
Yarrow Bioscience, Inc. -3.504
Faeth Therapeutics, Inc. -0.7894
Immuneering Corp. -0.3738

EPS Diluted (Quarterly) Related Metrics